News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

GeNOsys Inc. (GNYS) Retains Alliance Advisors, LLC to Implement Investor Relations Program


9/29/2008 9:32:03 AM

PROVO, UT--(Marketwire - September 29, 2008) - GeNOsys, Inc. (OTCBB: GNYS), a medical research and development company specializing in pharmaceutical, biotechnical and medical gas generating systems, today announced it has retained Alliance Advisors as the Company's investor relations representative. Alliance Advisors will immediately initiate a proactive and targeted investor relations campaign. Alan Sheinwald, of Alliance Advisors, and his team will be advising the Company in all facets of public financial communications.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES